Evidence map›Paper›PMID 24891105›Full record

ArticleInfection and immunity2014

A specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 component.

Luis Solans, Nacho Aguiló, Sofía Samper, Alexandre Pawlik, Wafa Frigui, Carlos Martín, Roland Brosch, Jesús Gonzalo-Asensio

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. bioRxiv : the preprint server for biology · 2025
    Article
  5. Assembly of theMicrobiology spectrum · 2025
    Article
  6. Evaluation of the role ofMicrobiology spectrum · 2025
    Article
  7. Journal of bacteriology · 2025
    Review
  8. Comparative transcriptomic signatures of virulent and attenuatedFrontiers in cellular and infection microbiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. TheMolecular therapy. Nucleic acids · 2022
    Article
  17. The Lack of the TetR-Like Repressor GeneFrontiers in cellular and infection microbiology · 2022
    Article
  18. Review
  19. Engineering a new vaccine platform for heterologous antigen delivery in live-attenuatedComputational and structural biotechnology journal · 2021
    Article
  20. Modeling Tubercular ESX-1 Secretion Using Mycobacterium marinum.Microbiology and molecular biology reviews : MMBR · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Luis SolansGrupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Nacho AguilóGrupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Sofía SamperGrupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain Servicio de Microbiología, Hospital Universitario Miguel Servet, ISS Aragón, Zaragoza, Spain.
Alexandre PawlikInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris, France.
Wafa FriguiInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris, France.
Carlos MartínGrupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain Servicio de Microbiología, Hospital Universitario Miguel Servet, ISS Aragón, Zaragoza, Spain.
Roland BroschInstitut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, Paris, France.
Jesús Gonzalo-AsensioGrupo de Genética de Micobacterias, Departamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain jagonzal@unizar.es.ORCID http://orcid.org/0000-0001-8841-6593
Institut Pasteur · FRCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESInstituto de Salud Carlos III · ESUniversidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ESX-1 secreted virulence factor ESAT-6 is one of the major and most well-studied virulence factors of Mycobacterium tuberculosis, given that its inactivation severely attenuates virulent mycobacteria. In this work, we show that clinical isolates of M. tuberculosis produce and secrete larger amounts of ESAT-6 than the widely used M. tuberculosis H37Rv laboratory strain. A search for the genetic polymorphisms underlying this observation showed that whiB6 (rv3862c), a gene upstream of the ESX-1 genetic locus that has not previously been found to be implicated in the regulation of the ESX-1 secretory apparatus, presents a unique single nucleotide insertion in its promoter region in strains H37Rv and H37Ra. This polymorphism is not present in any of the other publicly available M. tuberculosis complex genomes or in any of the 76 clinical M. tuberculosis isolates analyzed in our laboratory. We demonstrate that in consequence, the virulence master regulator PhoP downregulates whiB6 expression in H37Rv, while it upregulates its expression in clinical strains. Importantly, reintroduction of the wild-type (WT) copy of whiB6 in H37Rv restored ESAT-6 production and secretion to the level of clinical strains. Hence, we provide clear evidence that in M. tuberculosis--with the exception of the H37Rv strain--ESX-1 expression is regulated by WhiB6 as part of the PhoP regulon, which adds another level of complexity to the regulation of ESAT-6 secretion with a potential role in virulence adaptation.

Indexed as

Bacterial Secretion SystemsGene Expression Regulation, BacterialPolymorphism, Single NucleotideAntigens, BacterialBacterial ProteinsMycobacterium tuberculosisPromoter Regions, GeneticRegulonAntigens, BacterialBacterial ProteinsBacterial Secretion SystemsESAT-6 protein, Mycobacterium tuberculosisPhoP protein, Bacteria

Identifiers

PMID24891105
PMCPMC4136221
OpenAlexW2104847655

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.